Axil Brands, Inc. (AXIL) stock
AXILNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 6, 2026Score 19/3065% below fair value
$4.27−0.24 (-5.22%)
Close on Nov 20, 2026Market cap $29.13MP/E 12.6Yield –
Axil Brands free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Axil Brands's free cash flow for the twelve months ending Aug 31, 2026 was $4.37M, up 41683.6% year over year. For fiscal 2026 it was -$89.02K, down 105.2% from the year before. The highest annual figure on record is $2.85M in fiscal 2023.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | -$89.02K | -105.2% |
| FY2025 | May 31, 2025 | $1.72M | – |
| FY2024 | May 31, 2024 | -$135.77K | -104.8% |
| FY2023 | May 31, 2023 | $2.85M | +8544.2% |
| FY2021 | May 31, 2021 | $33.00K | – |
| FY2020 | May 31, 2020 | -$98.93K | – |
| FY2019 | May 31, 2019 | -$188.93K | – |
| FY2018 | May 31, 2018 | -$472.61K | – |
| FY2017 | May 31, 2017 | -$375.42K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | $3.71M | – |
| Q4 FY2026CQ2 2026 | May 31, 2026 | -$800.64K | -692.9% |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | $552.83K | – |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | $906.36K | -3.7% |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | -$747.56K | – |
| Q4 FY2025CQ2 2025 | May 31, 2025 | $135.04K | – |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | -$318.10K | -138.1% |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | $941.07K | +171.8% |
| Q4 FY2024CQ2 2024 | May 31, 2024 | -$394.90K | -167.7% |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -$922.14K | -919.5% |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | $835.06K | -37.4% |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | $346.21K | -56.8% |
| Q4 FY2023CQ2 2023 | May 31, 2023 | $583.47K | – |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | $112.53K | – |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | $1.33M | +849.7% |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | $801.23K | +15391.7% |
| Q4 FY2021CQ2 2021 | May 31, 2021 | -$25.81K | -125.2% |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | -$86.85K | – |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | $140.48K | +1646.6% |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | $5.17K | – |
| Q4 FY2020CQ2 2020 | May 31, 2020 | $102.27K | – |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | -$193.89K | -1333.7% |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | $8.04K | – |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | -$15.36K | – |
| Q4 FY2019CQ2 2019 | May 31, 2019 | -$54.83K | – |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | $15.72K | – |
| Q4 FY2018CQ2 2018 | May 31, 2018 | -$28.97K | – |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | -$91.05K | – |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | -$154.01K | – |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | -$198.59K | – |
See a number that looks wrong?